Skip to main content

Search

Show all results for

Home

Person

Maxim Norkin

About
Privacy
Disclaimer

Copyright © 2026 EPFL, all rights reserved

Graph Chatbot

Official source

https://people.epfl.ch/maxim.norkin

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Related publications (5)

Please note that this is not a complete list of this person’s publications. It includes only semantically relevant works. For a full list, please refer to Infoscience.

IFNγ-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy

Jörg Hülsken, Laurent Nam Ky Beziaud, Maxim Norkin, Angela Madurga Alonso

Despite the remarkable success of immune checkpoint blockade (ICB) therapy, most cancer patients still do not respond. We now find that immunotherapy can induce stem-like properties in tumors. Using mouse models of breast cancer, we observe that cancer ste ...

Elsevier BV2023

Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma

Jörg Hülsken, Maxim Norkin

Background We propose a new approach for designing personalized treatment for colorectal cancer (CRC) patients, by combining ex vivo organoid efficacy testing with mathematical modeling of the results. ...

BMC2023

Genomic Instability Profiles at the Single Cell Level in Mouse Colorectal Cancers of Defined Genotypes

Jörg Hülsken, Paloma Ordonez Moran, Maxim Norkin

The genomes of many human CRCs have been sequenced, revealing a large number of genetic alterations. However, the molecular mechanisms underlying the accumulation of these alterations are still being debated. In this study, we examined colorectal tumours t ...

2021

Related units (1)

Prof. Huelsken Group

EPFL
SV
ISREC
UPHUELSKEN